Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD)
Status:
Recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
Umbilical Cord-derived Mesenchymal stem cell has been proven effective in the experimental
bronchopulmonary dysplasia (BPD).A multi-center study was designed to evaluate the safety and
efficacy of the cellular therapy in extremely preterm infants at high risk for BPD.